# Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms

> **NCT00108849** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 309 (actual)

## Conditions studied

- Menopause
- Postmenopausal Vaginal Atrophy

## Interventions

- **DRUG:** estradiol, 10 mcg

## Key facts

- **NCT ID:** NCT00108849
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 309 (ACTUAL)
- **Last updated:** 2017-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00108849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00108849, "Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT00108849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*